Prepare your visit!
Monday, November 13, 2023SCCS

Butylparaben, Benzyl Salicylate: final Opinions of the SCCS

Butylparaben, Benzyl salicylate : Opinions finales du CSSC

Following the mandate given by the European Commission to the SCCS in the context of the safety assessment of substances with potential endocrine disrupting properties, the Scientific Committee has just published its final Opinions on Butylparaben (preservative) and Benzyl Salicylate (fragrance ingredient). They have been adopted during the plenary meeting of the SCCS on 26 October 2023.

Reading time
~ 5 minutes

Background on substances with endocrine disrupting properties

The European Commission committed to establishing a priority list of potential EDs not already covered by bans or restrictions in the Cosmetics Regulation for their subsequent safety assessment. A priority list of 28 potential EDs in cosmetics was established. The Commission carried out a public call for data for 14 substances (Group A) and a second call in 2021 for 10 substances (Group B) in preparation of the safety assessment of these substances.



Butylparaben (CAS No.94-26-8, EC No.202-318-7) is currently regulated as a preservative (Annex V entry 12a) in a concentration up to 0.14% (as acid) when used on its own or for the sum of its combined use with propylparaben and its salts (Annex V, entry 12a, column g).
During the call for data, stakeholders submitted scientific evidence to demonstrate the safety of Butylparaben as a preservative in cosmetic products.

For an exhaustive background information, see the articles
Endocrine disruptors: 2nd call for data from the European Commission, CosmeticOBS, 22 February 2021
Butylparaben, Homosalate: requests for SCCS Opinions, CosmeticOBS, 19 October 2021
Methylparaben, Butylparaben : preliminary Opinions of the SCCS, CosmeticOBS, 12 June 2023 …

This content is only available to subscribersPREMIUM, PRO, STARTUP and TPE

Already subscribed?Log in

Discover our subscriptions

CosmeticOBS' PRO services

SCCSOther articles